| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 51.19B | 42.90B | 42.67B | 33.24B | 29.70B |
| Gross Profit | 30.97B | 24.92B | 25.41B | 19.10B | 17.66B |
| EBITDA | 22.35B | 16.51B | 18.42B | 11.80B | 10.96B |
| Net Income | 15.46B | 12.12B | 12.08B | 8.50B | 7.16B |
Balance Sheet | |||||
| Total Assets | 65.20B | 53.16B | 49.14B | 39.25B | 32.90B |
| Cash, Cash Equivalents and Short-Term Investments | 18.75B | 12.25B | 24.23B | 15.29B | 14.99B |
| Total Debt | 4.49B | 3.75B | 3.21B | 2.52B | 2.59B |
| Total Liabilities | 25.71B | 20.87B | 20.57B | 15.17B | 12.15B |
| Stockholders Equity | 39.49B | 32.29B | 28.57B | 24.08B | 20.74B |
Cash Flow | |||||
| Free Cash Flow | 14.07B | 4.62B | 12.44B | 7.69B | 8.91B |
| Operating Cash Flow | 20.59B | 11.02B | 17.30B | 12.04B | 11.40B |
| Investing Cash Flow | -11.20B | -4.50B | -14.28B | -9.43B | -5.32B |
| Financing Cash Flow | -7.85B | -8.06B | -7.02B | -5.37B | -1.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | HK$3.81B | 3.41 | 12.93% | 3.74% | 22.72% | 41.32% | |
79 Outperform | HK$541.85B | 30.61 | 42.43% | 1.73% | 22.57% | 31.01% | |
73 Outperform | HK$110.85B | 24.14 | 20.39% | ― | ― | ― | |
71 Outperform | HK$32.65B | 15.79 | 15.41% | 5.64% | 4.51% | 10.64% | |
63 Neutral | HK$1.62B | 11.85 | 4.05% | ― | -0.48% | -29.65% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$7.61B | 23.14 | 8.86% | 1.41% | 4.96% | 64.85% |